Huntington National Bank’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60K | Buy |
6,700
+100
| +2% | +$896 | ﹤0.01% | 1174 |
|
|
2025
Q1 | $49.5K | Sell |
6,600
-60
| -0.9% | -$450 | ﹤0.01% | 1180 |
|
|
2024
Q4 | $50.1K | Sell |
6,660
-81
| -1% | -$609 | ﹤0.01% | 1193 |
|
|
2024
Q3 | $51.2K | Buy |
6,741
+53
| +0.8% | +$403 | ﹤0.01% | 1164 |
|
|
2024
Q2 | $41.3K | Sell |
6,688
-25
| -0.4% | -$154 | ﹤0.01% | 1192 |
|
|
2024
Q1 | $34.1K | Sell |
6,713
-151
| -2% | -$767 | ﹤0.01% | 1264 |
|
|
2023
Q4 | $41.1K | Buy |
6,864
+12
| +0.2% | +$72 | ﹤0.01% | 1151 |
|
|
2023
Q3 | $48.5K | Sell |
6,852
-142
| -2% | -$1.01K | ﹤0.01% | 1051 |
|
|
2023
Q2 | $49.2K | Buy |
6,994
+311
| +5% | +$2.19K | ﹤0.01% | 1057 |
|
|
2023
Q1 | $55.7K | Buy |
6,683
+1,140
| +21% | +$9.51K | ﹤0.01% | 967 |
|
|
2022
Q4 | $63.6K | Sell |
5,543
-39
| -0.7% | -$448 | ﹤0.01% | 915 |
|
|
2022
Q3 | $70K | Buy |
5,582
+1,081
| +24% | +$13.6K | ﹤0.01% | 882 |
|
|
2022
Q2 | $48K | Hold |
4,501
| – | – | ﹤0.01% | 1009 |
|
|
2022
Q1 | $73K | Hold |
4,501
| – | – | ﹤0.01% | 940 |
|
|
2021
Q4 | $62K | Hold |
4,501
| – | – | ﹤0.01% | 1000 |
|
|
2021
Q3 | $65K | Hold |
4,501
| – | – | ﹤0.01% | 898 |
|
|
2021
Q2 | $71K | Hold |
4,501
| – | – | ﹤0.01% | 838 |
|
|
2021
Q1 | $46K | Hold |
4,501
| – | – | ﹤0.01% | 876 |
|
|
2020
Q4 | $34K | Hold |
4,501
| – | – | ﹤0.01% | 931 |
|
|
2020
Q3 | $15K | Hold |
4,501
| – | – | ﹤0.01% | 1132 |
|
|
2020
Q2 | $21K | Hold |
4,501
| – | – | ﹤0.01% | 1009 |
|
|
2020
Q1 | $9K | Hold |
4,501
| – | – | ﹤0.01% | 1214 |
|
|
2019
Q4 | $16K | Hold |
4,501
| – | – | ﹤0.01% | 1309 |
|
|
2019
Q3 | $13K | Hold |
4,501
| – | – | ﹤0.01% | 1216 |
|
|
2019
Q2 | $17K | Buy |
4,501
+1
| +0% | +$4 | ﹤0.01% | 1181 |
|
|
2019
Q1 | $37K | Sell |
4,500
-1
| -0% | -$8 | ﹤0.01% | 924 |
|
|
2018
Q4 | $36K | Hold |
4,501
| – | – | ﹤0.01% | 952 |
|
|
2018
Q3 | $34K | Buy |
4,501
+1
| +0% | +$8 | ﹤0.01% | 1083 |
|
|
2018
Q2 | $26K | Buy |
+4,500
| New | +$26K | ﹤0.01% | 1142 |
|